Murine Ba/F3 cells were transfected with cDNA for the ␣-chain of the murine interleukin-5 (IL-5) receptor and cloned lines of these cells were able to proliferate in response to as little as 2.5 pg/ml of IL-5. The bioassay was demonstrated to be specific for IL-5 and was able to measure IL-5 produced in culture by organs from adult C57BL/6 and BALB/c mice. The highest levels of IL-5 were produced by lung tissue but thymus and bladder consistently produced IL-5 and more variable production was observed by the heart, spleen, muscle, bone shaft, uterus and testes. Bone marrow cells produced no detectable IL-5. Observed levels of production of IL-5 were similar when using organs from mice lacking high-affinity receptors for IL-5 and from nu/nu, RAG-1−/− and NOD/SCID mice lacking T lymphocytes. In inflammatory peritoneal exudates induced by the injection of casein plus bacteria, levels of induced IL-5 were higher if the mice lacked high-affinity receptors for IL-5. The data indicate that T lymphocytes are not the dominant cellular source of IL-5 in organ-conditioned media and that local IL-5 production can occur with a wide range of normal murine organs. Leukemia (2001Leukemia ( ) 15, 1248Leukemia ( -1255 
Introduction
Eosinophils are well recognized to be involved in acute and chronic inflammatory states and are likely to play an exceptional role in responses to helminths. However, eosinophils are also prominent in certain types of leukemia and lymphoma -either as members of the leukemic clone, as in chronic myeloid leukemia 1 or the acute myeloid leukemias with inversion of chromosome 16 2 or the 8:21 translocation, 3 or as normal host-responsive cells as in Hodgkin's disease. 4 For a broad understanding of the biology of eosinophils in such leukemic and lymphoma populations, it is necessary to characterize the regulatory control of eosinophils, both in normal health and in pathological states involving eosinophils.
From in vitro studies, only three regulatory factors are known to have the ability to stimulate the proliferation of normal eosinophil precursors -GM-CSF, 5 IL-3 6 and IL-5. 7 IL-3 is not detectable in normal mice 8 and transgenic GM-CSF mice do not have elevated eosinophil levels 9 whereas transgenic IL-5 mice do. 10 Conversely, inactivation of the GM-CSF gene does not reduce eosinophil numbers, 11 whereas inactivation of IL-5 does 12 and inactivation of the common ␤c receptor chain for GM-CSF and IL-5 markedly reduces eosinophil numbers. 13 These observations indicate that IL-5 is the major regulator of eosinophil production in vivo, perhaps aided by GM-CSF. It is of relevance therefore that there is expression of IL-5 receptors on leukemias with eosinophil subpopulations 14 and that such cells can respond to IL-5 stimulation by generating eosinophils. 2, 3 IL-5 was identified originally as a T lymphocyte product influencing B lymphocyte maturation 15 and stimulating eosinophil colony formation. 16 Furthermore, IL-5 was cloned from T lymphocytes 17 and has come to be regarded as being of predominantly T lymphocyte origin and, in particular, a product of TH 2 cells. 18 Subsequent studies have shown that IL-5 can be produced by activated mast cells 19 or eosinophils, 20 NK cells, 21 Reed-Sternberg cells 22 and transformed B lymphocytes. 23 However, little information exists on organ sources of IL-5 other than the documentation that IL-5 can be produced by lung and bronchial epithelial cells. 24 It is unclear therefore whether IL-5 has restricted organ sources or is of multi-organ origin, as in the situation for regulators such as GM-CSF, G-CSF or M-CSF. 8 Factor-dependent cell lines that express specific membrane receptors following transfection of cDNA for regulator receptors have proved to be reliable bioassay systems for detecting biologically active regulator molecules and for determining organ sites of production of these regulators. 8, 25 In the present studies, a specific and sensitive bioassay system for murine IL-5 was developed using Ba/F3 cells transfected with cDNA for the specific ␣-receptor chain of IL-5. Such cells were used to examine the capacity of various organs in the mouse to produce IL-5. The results have identified certain organs as constitutive producers of IL-5 and although the method does not allow the precise identification of the active cells in these tissues, the results make it improbable that lymphocytes, mast cells or eosinophils are the major cell types producing IL-5 in these tissues.
Materials and methods

Development of a cell line providing a specific bioassay for IL-5
The membrane receptor for IL-5 consists of a specific ␣-chain and a ␤-common chain shared by IL-5, GM-CSF and IL-3. 26 The Ba/F3 cell line was chosen because it expresses the ␤-common chain and only responds by proliferation to stimulation by IL-3. 25 Because IL-3 is not detectable in mouse serum or in media conditioned by normal mouse organs, 8 induced expression of IL-5 ␣-chains on Ba/F3 cells by transfection of cDNA for the IL-5 receptor ␣-chain would result in a cell line responding only to IL-5 in murine material of this type.
The parental Ba/F3 cell line was maintained in suspension culture in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum (FCS) and 10% medium conditioned by the murine WEHI-3B D − myelomonocytic leukemic cell line which contains IL-3. 27 Batches of 4 × 10 6 Ba/F3 cells were transfected by electroporation with 20 g of the pcDEF3/m IL-5R␣ plasmid (kindly supplied by Dr I Young, Australian National University, Canberra, Australia). This plasmid carries in linear array cDNA encoding both the IL-5R␣-chain receptor and the neomycin resistance genes. The cells were electroporated in mouse tonicity phosphate-buffered saline at 270 V and 960 F then incubated for 48 h in DMEM containing 10% FCS and 0.1% WEHI-3B D − conditioned medium as a source of IL-3. The cells were then washed three times, and 100 agar cultures were prepared each containing 30 000 of these Ba/F3 cells in 1 ml of DMEM with a final concentration of 10% FCS, 0.3% agar, 100 ng IL-5 and 1.2 mg G418. After 7 days of incubation at 37°C in a fully humidified atmosphere of 10% CO 2 in air, the cultures were inspected for the development of Ba/F3 colonies (usually one to three per dish). Individual colonies were transferred to wells containing 1 ml of DMEM 10% FCS and 100 ng IL-5. Transferred colonies showing progressive proliferation were expanded in suspension cultures using IL-5, then tested for quantitative responsiveness to IL-5 in microwell cultures.
Selection of a Ba/F3 IL-5R␣ line for bioassays
Each cloned Ba/F3 IL-5R␣ line was tested for its responsiveness to serial dilutions of IL-5 in microwell assays. Experiments showed that the concentration of IL-5 used in the maintenance cultures needed to be reduced to 125 pg/ml and the cells needed to be washed six times in 10 ml DMEM if residual IL-5 used in the maintenance cultures was to be adequately removed, allowing the cells to die in microwells containing no added stimulus. The line for routine use in bioassays was selected using three criteria: unequivocal death of unstimulated cells, maximal responsiveness to IL-5 stimulation and growth in microwells as a flat layer, permitting visual cell counts. For most cell lines, it was found that incubation for 72 h was required to ensure the death of all unstimulated assay cells.
Production of organ-conditioned media
All mice had been reared under barrier protection conditions. Organs were sterilely removed from C57BL/6 and BALB/c mice, aged 2-3 months, then coarsely minced with scissors and the organ fragments incubated in capped tubes containing 2 ml of serum-free DMEM. After incubation for 4 days at 37°C in a fully humidified atmosphere of 10% CO 2 in air, the media were harvested, then millipore filtered, and stored at 4°C until bioassayed.
In additional experiments 2-month-old mice lacking the ␤c receptor, 13 RAG-1−/−, NOD-SCID and NOD mice were used as organ sources for the preparation of conditioned medium.
Microwell assays of organ-conditioned media
The organ-conditioned media were assayed in 60-well plates (Sarstedt Australia, Technology Park, South Australia). Five l of each medium for assay was added to replicate wells using progressive two-fold dilutions in DMEM. Cells of the Ba/F3 IL-5R␣ cell line chosen for the bioassays were then washed six times in DMEM to remove the IL-5 used for maintenance of this cell line. Ten l of the Ba/F3 IL-5R␣ cell line, containing 200 cells, in DMEM with 10% FCS were then added to each well. In every experiment, trays were included containing serial dilutions of recombinant murine IL-5 (3 ng/ml) and IL-3 (1 ng/ml) (Pepro Tech, Rocky Hill, NJ, USA), together with control wells containing no added stimulus. For experiments using anti-mouse IL-5 antibodies, these were purchased from Sigma Chemical (St Louis, MO, USA).
The microwell trays were incubated for 72 h, at 37°C in a fully humidified atmosphere of 10% CO 2 in air. After incubation, the number of viable cells in each well was counted using an inverted microscope. In wells containing no added In most cases, the whole organ or both paired organs had been used to condition the medium (salivary gland, thymus, lung, heart, kidney, liver, spleen, bladder, testes and uterus). However for bone marrow and bone shafts, only the two femurs and their marrows were used, so the amounts of IL-5 detected were multiplied by 6 to estimate IL-5 production by total bone marrow or bone shaft cells. In the case of muscle, it was established that only 1/30th of the total body muscle mass had been used to condition the media and observed levels were multiplied by 30 to calculate total IL-5 production by skeletal muscle.
Induction of peritoneal exudates
Two-months-old ␤c−/− and control mice were injected intraperitoneally with 2 ml of an 0.2% (wt/vol) solution of casein in mouse tonicity phosphate-buffered saline (C-5890; Sigma Chemical) shown also to contain bacteria. 28 Three hours later, the mice were killed using penthrane anesthesia, the abdominal cavity injected with 2 ml of buffered saline and after mixing of the abdominal contents by massage, the peritoneal fluid was harvested using a soft plastic pipette.
RNA extraction and RT-PCR
Total cellular RNA was extracted then oligo-dT-primed first strand cDNA was synthesized from 2 g of total RNA using 40 units of AMV reverse transcriptase (Roche, Mannheim, Germany) in the presence of 80 units RNAsin, 1 g oligo-dT, 400 M dNTPs in standard buffer (50 mM Tris-HCl, 8 mM MgCl 2 , 30 mM KCl, 1 mM dithiothreitol, pH 8.5) for 60 min at 37°C. One-tenth of the cDNA was amplified in separate PCR reactions with IL-5-and ␤-actin-specific oligonucleotide primers in 50 l reactions containing 200 M dNTPs, 1 M primers, 1 unit Taq DNA polymerase and the buffer supplied (Roche). The reactions were cycled 30 times through a 96°C/30 s, 55°C/30 s, 72°C/40 s amplification protocol. Products were separated electrophoretically in 1.2% agarose gels, transferred to GeneScreen Plus (NEN Life Science, Boston MA, USA) nylon membranes and hybridized with specific internal oligonucleotides for visualization by autoradiography. Primers used were: IL-5 5Ј: AGG ATG CTT CTG CAC TTG A; IL-5 3Ј: ACA CCA AGG AAC TCT TGC A; IL-5 internal: TCA GGG GCT AGA CAT ACT GAA G; ␤-actin 5Ј: GTG GGC CGC TCT AGG CAC CAA; ␤-actin 3Ј: CTC TTT GAT GTC ACG CAC GAT TTC; ␤-actin internal: GGC TGT GCT GTC CCT GTA TGC CTC.
Statistical analysis
Analysis for significant differences between groups of media was performed using the Student's t-test as applied to the antilogs of the observed values.
Results
Responsiveness of transfected Ba/F3 IL-5R␣ cell lines
Fifty-one cloned lines of Ba/F3 IL-5R␣ cells were initiated from individual agar colonies of such cells and maintained in suspension cultures using stimulation by IL-5. These cell lines were then screened in microwell assays to establish their responsiveness to IL-5. Only one clone failed to respond to stimulation by IL-5 in microwell cultures. No autonomous cell lines were encountered but cell lines varied up to 1000-fold in their responsiveness to stimulation by IL-5, as shown by representative examples in Figure 1 . Forty-two cloned lines were discarded because their responsiveness to IL-5 was insufficient to detect very low concentrations of IL-5 or because they grew as cell clumps which made cell counting difficult. The remaining eight cloned lines all exhibited high responsiveness to IL-5 Of these, one line (clone 6), was chosen for routine use in bioassays because it reproducibly responded to IL-5 concentrations as low as 2.5 pg/ml and the responding cells grew in the microwell cultures as a single, nonclumped, layer.
IL-5 production by C57BL/6 and BALB/c organs
Medium conditioned for 4 days by normal organs from 2-to 3-months-old C57BL/6 and BALB/c mice were assayed in serial dilution using Ba/F3 IL-5R␣ clone 6 cells.
As shown in Figure 2a , for media conditioned by C57BL/6 organs, IL-5 was consistently detected in media conditioned by the thymus, lung and bladder. Activity was also detected less consistently in media conditioned by the heart, spleen, muscle, bone shaft, uterus and testes. Levels of activity in the thymus, lung, bladder and muscle were higher in media conditioned by male than female organs (P Ͻ 0.01).
Corresponding data for BALB/c organ-conditioned media are shown in Figure 2b . As before, IL-5 was consistently detected in media conditioned by the thymus, lung and blad- der with more variable activity detected in other types of media. For BALB/c organ-conditioned media, there were no significant sex differences other than for higher levels in female heart-conditioned media than for male. While the overall patterns of organ production of IL-5 were generally similar between C57BL/6 and BALB/c mice, levels of IL-5 produced by BALB/c heart, lung and uterus were higher than in media conditioned by the corresponding C57BL/6 organs (P Ͻ 0.01).
The active material in these organ-conditioned media was verified as being IL-5 by the use of specific IL-5 antibodies. As shown by the examples in Figure 3 , anti-IL-5 antibody eliminated all the proliferative effects of IL-5 or organ-conditioned media on the assay cell line but did not inhibit proliferative responses of the cell line to IL-3. These results indicated that the only active material for the cell line in the conditioned media was IL-5 and this was routinely confirmed with all conditioned media by assaying them in parallel on the parental Ba/F3 cell line. In agreement with previous observations, 8 all such assays were consistently negative (lower
Figure 3
The ability of antibodies to IL-5 to completely suppress all proliferative activity for Ba/F3 IL-5R␣ cells of organ-conditioned medium or rIL-5 but not of rIL-3. detection limit 1 pg/ml), excluding IL-3 as being present in any of the materials tested in this study.
A remote possibility was checked that active organ-conditioned media did not contain IL-5 but an inducing agent that induced the 200 target Ba/F3 IL-5R␣ cells to exhibit autocrine production of IL-5 which then stimulated cell proliferation. Batches of 10 6 Ba/F3 IL-5R␣ cells were incubated for 24 h with certified active media conditioned by lung or bladder tissue. mRNA from these cells was then analyzed for the presence of IL-5 mRNA by PCR analysis. In parallel, an analysis was performed on lung and bladder tissue after 24 h of incubation. As shown in Figure 4 , IL-5 mRNA was demonstrable in lung tissue. All Ba/F3 IL-5R␣ samples produced a faint IL-5-specific band that was of doubtful significance. This band, which was detectable in mRNA preparations from unstimulated Ba/F3 IL-5␣ cells, did not increase in intensity in preparations from cells stimulated by active organ-conditioned media (Figure 4) . No evidence was observed therefore that the active conditioned media might have induced or increased autocrine production of IL-5 by the target cells. Furthermore, even if minimal amounts of IL-5 are being produced by Ba/F3 IL-5R␣ cells, these are clearly insufficient to stimulate the sur-
Figure 4
RT-PCR analysis of IL-5 expression. Serial dilutions (1:1, 1:10 and 1:100 indicated by the arrow) of cDNA synthesized from mRNA extracted from incubated lung tissue (lung) or Ba/F3 IL-5␣ cells stimulated by saline (sal), IL-5, or medium conditioned by thymus (thy CM), lung (lung CM) or bladder (bla CM) were independently amplified with IL-5 and ␤-actin-specific primers. The products were separated on agarose gels, blotted and hybridized with gene-specific oligonucleotides. cDNA prepared from recombinant IL-5-expressing baculovirus-infected insect cells were used as a positive control (+).
Leukemia vival or proliferation of unstimulated cultured Ba/F3 IL-5␣ cells in microwell cultures. The assay is therefore detecting the presence of IL-5 produced by the tissues conditioning the medium.
Certain organs such as salivary gland, brain, bone marrow, pancreas and liver consistently failed to produce detectable IL-5. One possible reason for this might have been that any IL-5 produced may have been bound, internalized and degraded by IL-5 receptor-expressing cells in the organ being incubated -a possibility that seemed most likely for bone marrow populations. To explore this possibility, experiments were performed in which organ-conditioned media were prepared from mice lacking the ␤-common receptor chain 13 and therefore unable to express high-affinity receptors for IL-5. As shown in Figure 5 , no significant differences were observed between the pattern or levels of IL-5 in media conditioned by organs from ␤c−/− mice and those in media conditioned by organs from littermate control mice. Furthermore, no activity was detectable in media conditioned by the brain, marrow, pancreas or liver from ␤c−/− mice.
A more general reason for false negative results in biological assays on organ-conditioned media is the possible presence of inhibitory or toxic material for the assay cell line. Although such inhibitory materials will be reduced below active concentrations in the assays by serial dilution, their concentrations may be sufficient to mask the presence of low concentrations of IL-5. To test this possibility, serial dilutions of consistently negative organ-conditioned media were performed and 5 pg/ml IL-5 and assay cells were then added to each well.
The results ( Figure 6 ) indicated that media conditioned by certain organs did contain inhibitors able to mask the stimulating effects of added IL-5. Media identified as possessing such inhibitory activity were those conditioned by liver, brain, pancreas, spleen and salivary gland but not bone marrow. The bioassay system was therefore shown to be unable to reliably detect the presence of IL-5 in media conditioned by these organs if the IL-5 concentration was below 5-20 pg/ml and, for liver, if below 640 pg/ml.
The possibility was also checked that active organ-conditioned media might also contain inhibitory material that
Figure 5
Organs from mice lacking the ␤c-chain of the IL-5 receptor (␤c−/−) do not generate higher levels of IL-5 in conditioned medium than organs from control (w/w) mice.
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Figure 6
The ability of medium conditioned by various organs to inhibit the stimulating activity of 5 pg IL-5 added to cultures of Ba/F3 IL-5R␣ cells. Note that bone marrow-conditioned medium did not exhibit any inhibitory activity. might lead to underestimates of the concentration of IL-5 present. Using active media conditioned by lung, bladder and thymus, three types of mixing experiments were performed: a titration of a mixture of these conditioned media with 10 ng/ml IL-5, addition of a low concentration of IL-5 to serial dilutions of organ-conditioned media and addition of low concentrations of organ-conditioned media to serial dilutions of IL-5. In no instance was inhibitory activity observed with these organ-conditioned media.
Production of IL-5 by lymphocyte-depleted organs
Most of the literature on IL-5 production highlights the prominent ability of T lymphocytes to produce IL-5 in vitro. To explore whether T lymphocytes were a major source of IL-5 being produced in vitro by organ fragments, assays were performed on media conditioned by organs from lymphocytedeficient animals, in particular from BALB/c nu/nu, RAG-1−/− and NOD-SCID mice. As shown in Figure 7a , levels of IL-5 produced by organs from BALB/c nu/nu mice did not differ significantly from those produced by organs from control BALB/c mice. As shown in Figures 7b and c , a similar lack of difference was observed in the activity of media from RAG-1−/− and NOD-SCID mice vs control mice, with if anything higher levels of IL-5 being produced by the lung from lymphocyte-depleted than control mice. This suggests that lymphocytes were not a major source of the IL-5 being detected in these organ-conditioned media. This conclusion was supported by the fact that the conditioned media were not routinely prepared using 2-mercaptoethanol in the medium, which is essential for good lymphocyte survival in tissue culture. Deliberate addition of 5 × 10 −5 M 2-mercaptoethanol to medium during the production of organ-conditioned medium did not increase the range of organs producing detectable IL-5 and did not alter resulting IL-5 concentrations (data not shown).
IL-5 production in inflammatory peritoneal exudates
The intraperitoneal injection of casein plus microorganisms leads to a local acute inflammatory response within 3 h with the resulting inflammatory population dominated by neutrophilic granulocytes.
28 During the 3-h period, local concen-
Figure 7
The capacity of organs from mice lacking T lymphocytes to generate IL-5 equals or exceeds that exhibited by organs from control mice. (a) BALB/c nu/nu mice vs BALB/c mice; (b) C57BL/6 RAG-1−/− mice vs C57BL/6 mice; (c) NOD/SCID mice vs NOD mice.
trations of GM-CSF and G-CSF rise substantially and the elevation of GM-CSF is significantly increased if the mice lack ␤-common chain receptors, preventing internalization of GM-CSF by receptor-bearing cells.
28
The local production of IL-5 in the peritoneal cavity in this laboratory model of inflammation was monitored in normal mice and in mice lacking ␤-common chain receptors. In agreement with previous studies, no GM-CSF was detectable in peritoneal washout fluid from normal mice (data not shown) but, as shown in Figure 8 , GM-CSF was detectable 3 h after the injection of casein plus bacteria and levels were higher in ␤c−/− than in normal injected mice. A similar pattern was observed with IL-5. No IL-5 was detectable in washout fluid from normal mice but, 3 h after the injection of casein plus bacteria, IL-5 was detectable and levels were again higher in ␤c−/− than in control injected mice.
In addition to demonstrating that IL-5 production can be induced in vivo by the injection of casein and bacteria, the observations indicate that, in distinction from the organ-conditioned medium experiments, the presence of high-affinity receptors for GM-CSF and IL-5 did reduce observed levels of both regulators in the inflammatory fluid.
Discussion
All methods for attempting to identify organs that produce hematopoietic regulators have their limitations. Estimates of mRNA levels, whether by Northern or PCR analysis, document transcriptional activity but not necessarily the production and secretion of protein. Immunoassays have high specificity but an inability to distinguish antigenically intact, but functionally inactive, molecules from biologically active ones. Bioassays, even if specific, can encounter difficulties if toxic or inhibitory material is present. To establish the organ content of a regulator, whether by bioassay or immunoassay, does not necessarily provide a valid index of the rate of production of the regulator. The culture of intact organs to generate active material in conditioned medium carries additional problems if viability of the tissues is variable and may become misleading if transcription becomes elevated as a consequence of the culture procedure. Furthermore, such estimates merely identify an active organ but not the active cell types.
The present observations therefore have limitations to what may be concluded, suffering inevitably from some of the
Figure 8
The intraperitoneal injection of casein plus bacteria induces the appearance of IL-5 and GM-CSF in the peritoneal washout fluid and in both cases levels are higher in ␤c−/− mice than in control mice.
Leukemia above problems. Despite this, the present observations have yielded some positive information. Lung was identified as the most active organ producing IL-5, and exceeding the combined total of IL-5 produced by all other organs tested. The observed high activity of lung tissue is of interest in view of previous evidence that lung epithelial cells produce IL-5 constitutively. 24 Furthermore, even with animals raised under barrier conditions, some microbial activation of lung lymphocytes, eosinophils or mast cells might be expected. Two other organs also had a consistent ability to produce IL-5 -the thymus and bladder. More variably, activity was observed with heart, spleen, muscle, spleen, bone shaft, uterus and testes. Unfortunately, requirements for sterility prevented studies on two organs, the gut and skin, that might well have a significant capacity to produce IL-5, because the present studies showed that injected bacteria are an inductive stimulus for IL-5 production. Bone shaft cells might logically be expected to produce IL-5 as a stimulus for the active eosinophil proliferation occurring in adjacent marrow populations. The inability to detect IL-5 production by marrow populations themselves was surprising but this problem has been encountered previously with the inability to detect the production of G-CSF, GM-CSF or M-CSF by marrow cell suspensions. 8 The present experiments have eliminated receptor-mediated consumption or the presence of inhibitory material as explanations of this failure to detect activity with marrow populations.
The cell types responsible for the observed levels of IL-5 production cannot be determined from the present approach. However, lymphocytes seem unlikely to have contributed in a major manner to the observed IL-5 production because organs from lymphocyte-deficient nu/nu, NOD-SCID and RAG-1−/− mice had a normal capacity to produce IL-5. Activated mast cells and eosinophils have also been reported to produce IL-5 19, 20 as have lung and bronchial epithelial cells. 24 Comparable studies have not been reported for other cell types but it is possible that other cell types may have a capacity to produce IL-5, the more so because, for example, mast cells and eosinophils are not prominent in two organs with consistent IL-5-producing activity, the normal mouse bladder and thymus (DM, personal observations). The bioassay cell line used was highly responsive to IL-5, detecting concentrations as low as 2.5 pg/ml. Calculation of total organ production of IL-5 for organs other than the lung gave values in the tens to hundreds of pg/per organ, organ weights ranging from 50 to 400 mg. Are these concentrations high enough to be of functional relevance? In agar cultures, eosinophil colony formation by marrow cells is stimulated by concentrations of IL-5 as low as 100 pg/ml and the level of responsiveness of mature cells to functional stimulation by IL-5 may be even higher if the CSFs are a general guide to the situation. 29 The observed IL-5 concentrations could therefore be biologically relevant, particularly when acting locally on adjacent eosinophil precursors or mature cells.
The failure of T lymphocytes to emerge as important populations in the production of organ-conditioned medium raises a problem. In allergic states, the ability of mice to develop an elevated eosinophil response has been shown to be significantly T lymphocyte-dependent. 18 Does this indicate that the type of basal organ production of IL-5 measured in the present studies is not sufficient to stimulate an increased production and localization of eosinophils? In a situation requiring enhanced eosinophil production, this may be so and additional IL-5 may need to be produced by activated T lymphocytes. Resolution of this apparent discrepancy would require an analysis of the situation in allergic mice.
The same general issue arises when considering the regulation of eosinophils in leukemic and lymphoma populations. To what degree are these cells dependent on circulating IL-5, locally produced IL-5 or autocrine IL-5? The present studies indicate merely that locally produced IL-5 is available in many organs and that neoplastic populations responsive to and perhaps dependent on IL-5 need not, of necessity, produce their own IL-5, even in situations where therapy has severely reduced T lymphocyte numbers.
The present data indicate that a highly sensitive bioassay system is now available that should be of value in determining levels of IL-5 production by pathological mouse tissues and in establishing the impact of various experimental procedures on IL-5 production.
The overall similarity in the pattern of multi-organ IL-5 production to that of prototype regulators like GM-CSF, G-CSF and M-CSF 8 places IL-5 in this category of regulators having a multi-organ origin. This is in distinction from those regulators like erythropoietin and thrombopoietin that appear to have a much more restricted organ origin. The present data support earlier evidence that IL-5 can have a non-T lymphocyte origin 30 and caution against continuing to regard IL-5 as necessarily having a predominantly lymphocyte origin or as resulting from activation of particular T lymphocyte subsets.
